New cast for a new era: preclinical cancer drug development revisited
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
New cast for a new era: preclinical cancer drug development revisited
Authors
Keywords
-
Journal
JOURNAL OF CLINICAL INVESTIGATION
Volume 123, Issue 9, Pages 3639-3645
Publisher
American Society for Clinical Investigation
Online
2013-09-02
DOI
10.1172/jci68340
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Origin of the vasculature supporting growth of primary patient tumor xenografts
- (2013) Bonnie L Hylander et al. Journal of Translational Medicine
- In Vivo Imaging Enables High Resolution Preclinical Trials on Patients’ Leukemia Cells Growing in Mice
- (2013) Nadia Terziyska et al. PLoS One
- The Requirement for Cyclin D Function in Tumor Maintenance
- (2012) Yoon Jong Choi et al. CANCER CELL
- Genetically Engineered Mouse Models: Closing the Gap between Preclinical Data and Trial Outcomes
- (2012) M. Singh et al. CANCER RESEARCH
- Characterization of a Large Panel of Patient-Derived Tumor Xenografts Representing the Clinical Heterogeneity of Human Colorectal Cancer
- (2012) S. Julien et al. CLINICAL CANCER RESEARCH
- Cellular and Subcellular Imaging in Live Mice Using Fluorescent Proteins
- (2012) Robert M. Hoffman CURRENT PHARMACEUTICAL BIOTECHNOLOGY
- Genomic characterization of explant tumorgraft models derived from fresh patient tumor tissue
- (2012) David J Monsma et al. Journal of Translational Medicine
- Selumetinib plus docetaxel for KRAS-mutant advanced non-small-cell lung cancer: a randomised, multicentre, placebo-controlled, phase 2 study
- (2012) Pasi A Jänne et al. LANCET ONCOLOGY
- A murine lung cancer co-clinical trial identifies genetic modifiers of therapeutic response
- (2012) Zhao Chen et al. NATURE
- Patient-derived tumour xenografts as models for oncology drug development
- (2012) John J. Tentler et al. Nature Reviews Clinical Oncology
- A Model for Personalized in Vivo Analysis of Human Immune Responsiveness
- (2012) H. Kalscheuer et al. Science Translational Medicine
- Preclinical Testing of PI3K/AKT/mTOR Signaling Inhibitors in a Mouse Model of Ovarian Endometrioid Adenocarcinoma
- (2011) R. Wu et al. CLINICAL CANCER RESEARCH
- Humanized tumor mice-A new model to study and manipulate the immune response in advanced cancer therapy
- (2011) Anja K. Wege et al. INTERNATIONAL JOURNAL OF CANCER
- A Pilot Clinical Study of Treatment Guided by Personalized Tumorgrafts in Patients with Advanced Cancer
- (2011) M. Hidalgo et al. MOLECULAR CANCER THERAPEUTICS
- Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
- (2011) Yoko S DeRose et al. NATURE MEDICINE
- Cancer Immunoediting: Integrating Immunity's Roles in Cancer Suppression and Promotion
- (2011) R. D. Schreiber et al. SCIENCE
- The APL Paradigm and the “Co-Clinical Trial” Project
- (2011) Caterina Nardella et al. Cancer Discovery
- Quantifying the relative amount of mouse and human DNA in cancer xenografts using species-specific variation in gene length
- (2010) Ming-Tseh Lin et al. BIOTECHNIQUES
- Establishment and characterisation of a new breast cancer xenograft obtained from a woman carrying a germline BRCA2 mutation
- (2010) L de Plater et al. BRITISH JOURNAL OF CANCER
- DNA Damage-Mediated Induction of a Chemoresistant Niche
- (2010) Luke A. Gilbert et al. CELL
- Establishing humanized mice using stem cells: maximizing the potential
- (2010) D. Bernard et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Patient-Derived First Generation Xenografts of Non-Small Cell Lung Cancers: Promising Tools for Predicting Drug Responses for Personalized Chemotherapy
- (2010) X. Dong et al. CLINICAL CANCER RESEARCH
- Treating triple-negative breast cancer by a combination of rapamycin and cyclophosphamide: An in vivo bioluminescence imaging study
- (2010) Qing Zeng et al. EUROPEAN JOURNAL OF CANCER
- Assessing therapeutic responses in Kras mutant cancers using genetically engineered mouse models
- (2010) Mallika Singh et al. NATURE BIOTECHNOLOGY
- The benefits and limitations of animal models for translational research in neurodegenerative diseases
- (2010) Mathias Jucker NATURE MEDICINE
- Preclinical development of molecular-targeted agents for cancer
- (2010) Alberto Ocana et al. Nature Reviews Clinical Oncology
- Bioluminescent Approaches for Measuring Tumor Growth in a Mouse Model of Neurofibromatosis
- (2010) Jessica J. Hawes et al. TOXICOLOGIC PATHOLOGY
- Functional Identification of Tumor-Suppressor Genes through an In Vivo RNA Interference Screen in a Mouse Lymphoma Model
- (2009) Anka Bric et al. CANCER CELL
- Patterns of Gene Expression and Copy-Number Alterations in von-Hippel Lindau Disease-Associated and Sporadic Clear Cell Carcinoma of the Kidney
- (2009) R. Beroukhim et al. CANCER RESEARCH
- Management and interpretation of novel toxicities of molecular targeted therapies: Renal toxicities
- (2009) Joan Carles et al. EUROPEAN JOURNAL OF CANCER
- Cardiovascular toxicity of molecularly targeted agents
- (2009) Elizabeth L. Strevel et al. EUROPEAN JOURNAL OF CANCER
- Gastrointestinal toxicities of novel agents in cancer therapy
- (2009) Amani Asnacios et al. EUROPEAN JOURNAL OF CANCER
- Skin toxicities of targeted therapies
- (2009) Siegfried Segaert et al. EUROPEAN JOURNAL OF CANCER
- Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?☆
- (2009) Johannes Merk et al. EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY
- Chimeric mouse tumor models reveal differences in pathway activation between ERBB family– and KRAS-dependent lung adenocarcinomas
- (2009) Yinghui Zhou et al. NATURE BIOTECHNOLOGY
- Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
- (2009) K. P. Olive et al. SCIENCE
- Establishment of Patient-Derived Non-Small Cell Lung Cancer Xenografts as Models for the Identification of Predictive Biomarkers
- (2008) I. Fichtner et al. CLINICAL CANCER RESEARCH
- Mouse xenograft models vs GEM models for human cancer therapeutics
- (2008) A. Richmond et al. Disease Models & Mechanisms
- New response evaluation criteria in solid tumours: Revised RECIST guideline (version 1.1)
- (2008) E.A. Eisenhauer et al. EUROPEAN JOURNAL OF CANCER
- From Human to Mouse and Back: 'Tumorgraft' Models Surge in Popularity
- (2008) K. Garber JNCI-Journal of the National Cancer Institute
- Sorafenib in Advanced Hepatocellular Carcinoma
- (2008) Josep M. Llovet et al. NEW ENGLAND JOURNAL OF MEDICINE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now